Status:
COMPLETED
Cardiac COVID-19 Health Care Workers
Lead Sponsor:
AORTICA Group
Collaborating Sponsors:
Salamanca University Hospital
Instituto de Investigación Biomédica de Salamanca
Conditions:
SARS-CoV 2
COVID-19
Eligibility:
All Genders
18-71 years
Brief Summary
The study will analyze the prevalence of cardiac involvement of health care workers from the University Hospital of Salamanca (HUSA) who have overcome SARS-CoV-2 infection. Participants will undergo a...
Detailed Description
Most people infected with SARS-CoV-2 experience mild, self-limiting symptoms that have been managed in an outpatient setting and therefore have not undergone routine cardiac evaluation with EKG or car...
Eligibility Criteria
Inclusion
- Have overcome the SARS-CoV-2 infection meeting any of the following criteria (i) positive result on a reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay of a specimen collected on a nasopharyngeal swab followed by a second negative RT-PCR and at least 14 days from this negative RT-PCR; (ii) presence of IgM antibodies and negative RT-PCR after the antibody assessment; (iii) presence of neutralizing IgG antibodies and absence of IgM.
- stable clinical situation, which allows performing a CMR.
- signature of informed consent.
Exclusion
- Presence of IgM antibodies without negative subsequent RT-PCR.
- Contraindications to perform RMC: (i) gadolinium allergy, (ii) presence of metallic material in the body, such as plates, screws, incompatible pacemakers, etc. (iii) claustrophobia, (iv) severe kidney failure, (v) severe liver failure, (vi) sickle cell anemia
Key Trial Info
Start Date :
May 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 12 2020
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT04413071
Start Date
May 25 2020
End Date
June 12 2020
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Salamanca
Salamanca, Spain, 37007